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Summary: A comparison was made between the aminotransf erase activities of a number of plasma or serum samples
in 4 reaction media: phosphate buffer, phosphate buffer + pyridoxal-5'-phosphate, tris buffer and tris buffer +
pyridoxal-5'-phosphate. The reactions were carried out in the various buffer systems on the same day at 35 °C
on an automatic kinetic enzyme system (AKES, Vitatron, Dieren, the Netherlands).
The highest enzymic activity of both aminotransferases is observed in tris buffer + pyridoxal-5'-phosphate. The
activity is about 10-15%higher than in phosphate buffer + pyridoxal-5'-phosphate. Without supplementary
pyridoxal-5'-phosphate the differences between both buffer systems are lower or absent.
It appears necessary, therefore,, to determine the activity of both aminotransferases in a buffer system with tris and
to add pyridoxal-5'-phosphate, since assays should be carried out in the presence of optimal concentrations of any
of the necessary factors.
Bestimmung der Aminotransferase-Aktivität:
Vergleich von zwei Puffersystemen mit und ohne Zugabe von Pyridoxal-5'-phosphat
Zusammenfassung: Es wird ein Vergleich gezogen zwischen den Aminotransferase-Aktivitäten von einer Anzahl
Plasma- und Serumproben in 4 Testansätzen: Phosphatpuffer, Phosphatpuffer + Pyridoxal-5'-phosphat, Trispuffer
und Trispuffer + Pyridoxal-5'-phosphat. An ein und demselben Tag wurden die Bestimmungen durchgeführt bei 35 °C
am Automatic Kinetic Enzyme System (AKES, Vitatron, Dieren, die Niederlande).
Man findet die höchste Enzymaktivität beider Aminotransferasen in Trispuffer + Pyridoxal-5'-phosphat. Die Aktivität
ist etwa 10-15% höher als in Phosphatpüffer + Pyridoxal-5'-phosphat. Ohne den Zusatz von Pyridoxal-5'-phosphat
sind die Differenzen zwischen beiden Puffersystemen geringer oder fehlen.
Es ist darum wichtig, die Aktivität beider Aminotransferasen in einem Püffersystem mit Trispuffer unter Zugabe von
Pyridoxal-5'-phosphat zu bestimmen, da Erizymbestimmungen unter Zusatz von allen wichtigen Faktoren in opti-
maler Konzentration durchgeführt werden sollen.
Introduction (2), but tris would to be better for aminotransferases,
because of the increased NADH stability in this system
Karmen (1) in 1955 introduced the malate dehydroge- ^ ^ ̂
nase/NADH coupled assay for the measurement of serum
aspartäte aminptransferase activity. Most techniques Although some recommendations (2,5) do not include
which have been introduced since then for the determi- the use of pyridoxal-5'-phosphate in the measurement of
nation of aminotransferase activities are adaptations of aminotransferases it is now well established, that this
NADH dependent enzyme reactions. Until recently the coenzyme enhances the activity of these enzymes (6, 7,
most commonly employed buffer system was a phosphate 8, 9). Also the Expert Panel on Enzymes of the Committee
buffer. Die Deutsche Gesellschaft für Klinische Chemie on Standards of the IFCC has proposed the use of tris
in 1972 also recommended the use of a phosphate buffer buffer for the determinations of aspartate aminotrans- .
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ferase activity (10). Pyridoxal-5'-phosphate must be
added for maximal enzymic activity.
It is now important to be aware of the similarities and
differences between the new recommendations and the
formerly accepted methods. We have, therefore, tested
the aspartate aminotransferase and alanine aminotrans-
ferase activities of a number of plasma and serum samples
in phosphate and tris buffer with and without supple-
mentary pyridoxal-S'-phosphate.
Tab. 1. Reagent blank rates of alanine and aspartate aminotrans-
ferase in 4 reaction media. Catalytic concentrations are
expressed as the mean of 16 determinations.






Phosphate buffer + PLP 4.7






Blood was taken from patients or normal individuals by
venipuncture. After centrifugation the plasma (heparinised) or
serum samples were stored at + 4 °C and assayed for aminotrans-
ferase activity within 24 h after the collection of the blood.
The aminotransferase activities were determined according to the
following methods, in which the reaction medium containing
phosphate buffer was compared with the medium containing
tris buffer. All determinations were carried out in the absence
or presence of pyridoxal-5'-phosphate. In this way 4 comparable
sets of results were obtained.
The final reaction mixture for the aspartate aminotransferase
estimation contained per liter; tris buffer pH 7.7 20 mmol or
phosphate buffer pH 7.7 80 mmol, Ζ,-aspartate 200 mmol,
EDTA 5 mmol, lactate dehydrogenase (EC 1.1.1.27) > 200 U,
malate dehydrogenase (EC 1.1.1.37) > 600 U, NADH 0.15 mmol
and 2-oxoglutarate 12 mmol. The volume fraction of sample
was 0.15. The assay mixture for the alanine aminotransferase
contained per liter: tris buffer pH 7.4 20 mmol or phosphate
buffer pH 7.4 80 mmol, L-alanine 400 mmol, EDTA 5 mmol,
lactate dehydrogenase > 2000 U, NADH 0.15 mmol and 2-oxo-
glutarate 12 mmol. The volume fraction of sample was 0.15.
Enzyme reaction rates were measured at 35 °C on the Automatic
Kinetic Enzyme System (AKES, Vitatron, Dieren, the Nether-
lands), at 340 nm with a linearity setting of 10%. To 0.1 ml
plasma or serum 0.5 ml reaction medium was added. After
preincubation the reaction was started by the addition of 0.05 ml
2-oxoglutarate. All catalytic concentrations are expressed in U/1.
For the determinations with phosphate buffer the Boehringer
optimized standard methods (Catalogue number 15751 and
15752) were used and for those with tris buffer the Merck test
automation pack (Catalogue number 11369 and 11370) were
used. Pyridoxal-5'-phosphate was purchased from Merck.
Statistical analysis was performed using Students'-t test for paired
observations.
Results and Discussion
The reagent blank rates were determined in the 4 various
reaction media by replacing the serum by water (table 1).
The sample blank rate determined by starting the reaction
by water instead of 2-oxoglutarate did not give any
activity. Our blank rates agree with those of Harder et l
(l 1), who found a lower reagent blank rate in the absence
than in the presence of pyridoxal-S'-phosphate in a reaction
medium containing tris buffer. We did not correct for
both blank rates in our determinations, because this is
not directly possible in the Automatic Kinetic Enzyme
System (AKES) and because, in our opinion, it is not
generally usual in routine kinetic determinations of
enzymes.
Tab. 2. Activity of alanine and aspartate aminotransferase in
4 reaction media. Catalytic concentrations are expressed




χ η ρ χ η ρ
Phosphate buffer 37.8 168 37.8 203
n. s. <0.001
Tris buffer 38.1 168 39.9 203
Phosphate buffer + PLP 41.3 168 43.9 203
<0.001 <0.001
Tris buffer + PLP 47.3 168 48.5 203
Table 2 shows the enzymic activity of various serum or
plasma samples of patients or normal individuals. Addi-
tion of pyridoxal-5'-phosphate to the reaction media
caused a higher activity of both aminotransferases. The
enzymic activities determined in tris buffer with supple-
mentary pyridoxal-S'-phosphate are higher than in phos-
phate buffer with pyridoxakS'-phosphate. Without
supplementation with pyridoxal-5'-phosphate a higher
activity in tris buffer is only observed for the aspartate
aminotransferase. For the alanine aminotransferase the
activities in both buffer systems without pyridoxal-5'-
phosphate are identical. The reactivation of the apoenzyme
by pyridoxal-S'-phosphate is faster in tris buffer than in
phosphate buffer for both aminotransferases.
Our results agree with those ofEbeling et al (3), who did
not perform any statistical analysis, but it may be con-
cluded from their data, that a significantly (n = 25;
p < 0.05) higher aspartate aminotransferase activity is
observed in tris buffer than in phosphate buffer without
the addition of pyridoxal-5'-phosphate. They did not
observe a difference for the alanine aminotransferase.
Ref & Vanderlinde (12) demonstrated also a slightly (5%)
but significantly higher aspartate aminotransferase
activity in tris buffer than in phosphate buffer. The
highest enzyme activity of the aminotransferases is
demonstrated when the assays are carried out in tris
buffer with supplementary pyridoxal-S'-phosphate. In
phosphate buffer the activity is 10-15% lower than in
tris buffer with added pyridoxal-S'-phosphate. Re} et al.
(12,13) observed the same phenomenon! for the aspartate
J. Clin. Chem. Clin. Biochem. / VoL 15,1977 / No. 9
Hafkenschcid and Out: Determination of the activity of aminotransferases in two buffer systems 521
aminotransferase activity, although they did not perform
a direct comparison for both buffer systems. Our results
are also in agreement with observations ofRodgerson
(14). As far as we know, this difference in enzymic
activity in the 2 buffer systems with supplementary
pyridoxal-5'-phosphate has not yet been described for
the aJanine aminotransferase.
It appears, therefore, necessary to determine both aspartate
and alanine aminotransferase activity in tris buffer and
to add pyridoxal-5'-phosphate, because assays should
always be carried out in the presence of optimal concen-
trations of any necessary factors (15).
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